Nevada Administrative Code
Chapter 639 - Pharmacists and Pharmacy
GENERAL PROVISIONS
Section 639.Sec. 1.4 - NEW

Universal Citation: NV Admin Code 639.Sec. 1.4

Current through September 16, 2024

1. An oncology group practice that wishes to maintain a single inventory of dangerous drugs, excluding compounded drug products, received at a site of practice in lieu of maintaining separate inventories for each dispensing practitioner of the oncology group practice must apply to the Board on an application provided by the Board for a certificate of registration and submit the fee prescribed in NAC 639.220 for authorization of a practitioner, other than a licensed veterinarian, to dispense dangerous drugs. An oncology group practice must submit a separate application and fee for each site of practice at which the oncology group practice wishes to maintain a single inventory of dangerous drugs, excluding compounded drug products.

2. Upon receipt of a fee and approval of an application, the Board will issue a certificate of registration to an oncology group practice.

3. To renew a certificate of registration, an oncology group practice must submit to the Board another completed application and the fee prescribed in NAC 639.220 for biennial renewal of authorization of a practitioner, other than a licensed veterinarian, to dispense dangerous drugs.

4. A certificate of registration issued pursuant to this section:

(a) Entitles the oncology group practice to maintain a single inventory of dangerous drugs, excluding compounded drug products, at the site of practice for which the oncology group practice received certification.

(b) Is a revocable privilege, and no holder of such a certificate of registration acquires any vested right therein or thereunder.

5. An oncology group practice registered pursuant to this section shall provide written notice to the Board of the addition to or removal of a dispensing practitioner from the oncology group practice not later than 15 days after the addition or removal, as applicable.

6. A dispensing practitioner of an oncology group practice registered pursuant to this section:

(a) May dispense any dangerous drug accounted for in the single inventory of the oncology group practice.

(b) Shall ensure that he or she complies with the requirements prescribed by NAC 639.745, including, without limitation, maintaining separate records of each dangerous drug dispensed by him or her.

7. As used in this section:

(a) "Compounded" has the meaning ascribed to "compound" and "compounding" in NAC 639.6625.

(b) "Drug product" has the meaning ascribed to it in NAC 639.6631.

Added to NAC by Bd. of Pharmacy by R007-21A, eff. 6/13/2022; A by R007-21RA, eff. 6/13/2022;A by R181-22A, eff. 12/7/2022

NRS 639.070

Disclaimer: These regulations may not be the most recent version. Nevada may have more current or accurate information. We make no warranties or guarantees about the accuracy, completeness, or adequacy of the information contained on this site or the information linked to on the state site. Please check official sources.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.